EVIDENCE-BASEDAWAITING CLINICIAN REVIEW

Dexamethasone

WHO ATCH02AB02INNDexamethasone

Dexamethasone is a potent, long-acting corticosteroid used across many specialties. Benefits and risks depend strongly on dose, route and duration, so “dexamethasone” is not a single standard regimen.

At a glance

Quick facts

Drug snapshot
Drug class
Long-acting systemic corticosteroid
Main uses
A broad range of inflammatory, allergic, autoimmune, oncologic and endocrine indications; route and dose depend on condition
Route
Oral, intravenous, intramuscular and route-specific local formulations
WHO ATC
H02AB02
Key safety
Infection risk, hyperglycaemia, psychiatric effects, gastrointestinal complications, bone loss, eye effects and adrenal suppression with sufficient exposure.
Monitoring
Indication, dose and duration; glucose, blood pressure, infection risk, bone health, eye risk and adrenal suppression when relevant.

Names & terminology

How this medicine may be named or searched

Canonical page name
Dexamethasone
INN / generic name
Dexamethasone
Aliases / salts
dexamethasone · dexamethasone sodium phosphate
Russian support entity
dexamethasone.ru — entity relationship only, not a clinical source

Structured drug profile

Drug profile

INN data
INNDexamethasoneInternational nonproprietary / generic name used for this entity.
WHO ATCH02AB02Anatomical Therapeutic Chemical classification; route-specific codes may differ for some medicines.
Drug classLong-acting systemic corticosteroidPharmacologic / therapeutic class.
MechanismActivates glucocorticoid receptors and changes gene transcription, producing potent anti-inflammatory and immunosuppressive effects.Mechanism summarized at reference level.
RouteOral, intravenous, intramuscular and route-specific local formulationsAvailable routes depend on the specific product.
Main usesA broad range of inflammatory, allergic, autoimmune, oncologic and endocrine indications; route and dose depend on conditionApproved indications can differ by country and formulation.
Key safety contextInfection risk, hyperglycaemia, psychiatric effects, gastrointestinal complications, bone loss, eye effects and adrenal suppression with sufficient exposure.Check exact product labeling and patient-specific contraindications.
Monitoring / reviewIndication, dose and duration; glucose, blood pressure, infection risk, bone health, eye risk and adrenal suppression when relevant.Monitoring depends on indication, dose, route and patient factors.

What is Dexamethasone?

Dexamethasone is a potent, long-acting corticosteroid used across many specialties. Benefits and risks depend strongly on dose, route and duration, so “dexamethasone” is not a single standard regimen.

What is Dexamethasone used for?

A broad range of inflammatory, allergic, autoimmune, oncologic and endocrine indications; route and dose depend on condition. The exact approved indication depends on the product, route and country. [1]

How it works

Activates glucocorticoid receptors and changes gene transcription, producing potent anti-inflammatory and immunosuppressive effects.

Forms and formulations

Tablets and oral liquids; injectable, ophthalmic and other formulations vary by market. Different formulations may have different indications, strengths, excipients and instructions and should not be assumed interchangeable.

Country / market layer

Availability and formulations by market

Brand names, strengths, prescription status and approved uses vary by jurisdiction. Check the exact national product record before relying on a formulation.

Market-specific
🇬🇧
United KingdomSearch current eMC product information
Search eMC ↗

Availability depends on the active ingredient, route and formulation; not every medicine in this reference has a current UK product.

This English reference was selected because DiseasesConditions.org also maintains an entity relationship to the project’s Russian-language support site dexamethasone.ru. The Russian site is not used as a clinical source for this page.

How it is used

Follow the exact prescription. Oral dexamethasone schedules may be daily, intermittent or short-course depending on the indication. After prolonged or high-dose systemic treatment, abrupt discontinuation can be unsafe because endogenous adrenal function may be suppressed.

For prescription treatment, use the patient-specific regimen rather than copying a dose from another person or another formulation.

Side effects

Short-term effects can include insomnia, mood change, increased appetite, indigestion and higher blood glucose. Longer or repeated courses can contribute to osteoporosis, muscle weakness, cataracts, glaucoma, skin thinning and infection risk.

Important warnings and monitoring

Urgent review is warranted for severe infection symptoms, major mood or behavioural change, vision loss, gastrointestinal bleeding or adrenal-crisis symptoms after inappropriate withdrawal. Live vaccines may be unsuitable during immunosuppressive systemic therapy.

Monitoring context: Indication, dose and duration; glucose, blood pressure, infection risk, bone health, eye risk and adrenal suppression when relevant.

Interactions

Interactions include medicines that alter CYP3A metabolism, glucose-lowering medicines, anticoagulants, NSAIDs and vaccines. Dexamethasone itself can alter metabolism of other drugs.

Pregnancy and breastfeeding

Corticosteroids are sometimes necessary during pregnancy, but drug choice, route, dose and duration should be individualized. Do not abruptly stop chronic systemic dexamethasone because of pregnancy without specialist advice.

Overdose and accidental extra doses

A single extra dose may not cause severe toxicity in every case, but repeated excessive exposure can cause significant metabolic and psychiatric effects. Large or intentional overdose requires urgent assessment.

Practical clinical context

The most important distinction is between the medicine entity and a specific marketed product. Strength, salt, route, modified-release design, age authorization and prescription status can change between products. When safety or dosing decisions matter, use the exact package leaflet, prescribing information or national regulator record for the product actually being used.

This page deliberately separates general evidence from the project’s Russian-language support site dexamethasone.ru; that site identifies the cross-language entity but is not treated as an authority for clinical claims.

Common questions

Frequently asked questions

AWAITING CLINICIAN REVIEW

Sources

Clinical statements in this reference are based on named public-health, regulatory or guideline sources. Product-specific labeling remains authoritative for exact indications, dosing and contraindications.

  1. 1. MedlinePlus. Dexamethasone Drug Information. Source ↗
  2. 2. MedlinePlus. Dexamethasone Injection Drug Information. Source ↗

This medicine reference is evidence-based and is awaiting clinician review. It is not a substitute for personalized medical advice.